Novalis Biotech Incubation: Seeding and funding early-stage biotech startups for stakeholder value.
Location
Ghent, East Flanders, BE
Founded
2018
Novalis Biotech Incubation focuses on seeding and funding early-stage biotechnology and life sciences startups. They typically invest in seed rounds, providing essential capital to help nascent companies grow and develop their business strategies. By leveraging their professional and academic connections, Novalis Biotech aims to create significant value for all stakeholders involved.
Notable portfolio companies include Modality.AI, which has raised over $3.6 million, and Alithea Genomics, a leader in large-scale RNA sequencing and transcriptomics. Novalis Biotech's investment philosophy centers on nurturing innovation in the biotech sector, offering not just financial support but also strategic guidance and industry connections to help startups succeed.
Novalis Biotech - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies2
Follow-on Investments1
Current Portfolio Count2
Top Investment Stages
Seed3 (100.0%)
Stage Mix
Seed 100%
Concentration shown as share of disclosed investments by stage.
